Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study

Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer

NCT00201331 ·Status: UNKNOWN ·Phase: PHASE2

Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors

NCT00138177 ·Status: COMPLETED ·Phase: PHASE1

Second-line Surufatinib Combined With Chemotherapy in Advanced CRC

NCT04734249 ·Status: UNKNOWN ·Phase: PHASE2

Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer

NCT01071655 ·Status: COMPLETED ·Phase: PHASE2

Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer

NCT05424692 ·Status: RECRUITING ·Phase: NA

A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

NCT00040391 ·Status: TERMINATED ·Phase: PHASE2

CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

NCT02232152 ·Status: COMPLETED ·Phase: PHASE1

Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer

NCT00209625 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study

NCT01744353 ·Status: COMPLETED ·Phase: PHASE1

Trifluridine/Tipiracil Plus Fruquintinib vs. Trifluridine/Tipiracil Plus Bevacizumab in Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-Label, Non-Inferiority Trial

NCT07261709 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques

NCT01704703 ·Status: COMPLETED ·Phase: PHASE2

Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer

NCT03883802 ·Status: UNKNOWN ·Phase: PHASE2

Combination Chemotherapy in Treating Patients With Colorectal Cancer

NCT00039208 ·Status: COMPLETED ·Phase: PHASE2

Cardiotoxicity and Risk Factors in Patients With Colorectal Cancer Receiving Fluoropyrimidine

NCT02665312 ·Status: UNKNOWN

FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients

NCT02935764 ·Status: UNKNOWN ·Phase: PHASE3

Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer

NCT00831181 ·Status: COMPLETED ·Phase: PHASE2

Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer

NCT05832398 ·Status: RECRUITING ·Phase: NA

wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients

NCT01736904 ·Status: UNKNOWN ·Phase: PHASE2

Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy

NCT01126866 ·Status: TERMINATED ·Phase: PHASE2

A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients

NCT01183494 ·Status: COMPLETED ·Phase: PHASE1

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

NCT03337087 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer (FOLFIRINOX 3)

NCT03795311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients

NCT02655952 ·Status: COMPLETED ·Phase: PHASE1

Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer

NCT00004931 ·Status: COMPLETED ·Phase: PHASE3

Combination Chemotherapy in Treating Patients With Resected Colon Cancer

NCT00378716 ·Status: COMPLETED ·Phase: PHASE3